Compare Air Products & Chemicals, Inc. (APD) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Air Products & Chemicals, Inc. vs Sana Biotechnology Inc — how do they compare? Air Products & Chemicals, Inc. trades at $305.23 (market cap $68.88B), while Sana Biotechnology Inc trades at $3.77 (market cap $1.13B). The key difference: Air Products & Chemicals, Inc. is far larger — about 61× Sana Biotechnology Inc's market cap, and Air Products & Chemicals, Inc. pays a 2.34% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| APD | SANA | |
|---|---|---|
Market Cap | $68.88B | $1.13B |
Sector | Basic Materials | Health |
52-Week High | $314.19 | $5.92 |
52-Week Low | $230.42 | $2.68 |
Enterprise Value | $86.06B | $1.05B |
Dividend Yield | 2.34% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
APD trades at $305.54, down 0.86% on the day, with a bullish technical outlook supported by moving averages and recent earnings beats. The company reported Q3 2026 EPS of $3.47, exceeding expectations, and secured a long-term semiconductor supply deal in Taiwan. However, negative net income margin and elevated debt levels present fundamental concerns.
The stock offers upside to the $346 consensus price target, driven by volume growth and strategic contracts, but faces risks from high valuation multiples and leverage. Investor sentiment is positive amid raised guidance, though profitability challenges warrant caution.
SANA Biotechnology trades at $3.77, up 4.43% today, with a bullish technical signal from moving averages and ADX indicators. The company reported a net loss of $244.17 million for 2025, with negative cash flow from operations, but analyst consensus is strongly positive with 82% buy ratings. Recent news highlights clinical data presentations and a $9.50 average price target from brokerages as of July 30, 2026.
The outlook hinges on clinical progress driving future profitability, but high cash burn and negative ROE pose significant risks. Upside potential exists if pipeline milestones are met, supported by institutional optimism, though investors face volatility from earnings misses and funding needs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Air Products & Chemicals, Inc.
Since its founding in 1940, Air Products has become one of the leading industrial gas suppliers globally, with operations in 50 countries and 19,000 employees. The company is the largest supplier of hydrogen and helium in the world. It has a unique portfolio serving customers in a number of industries, including chemicals, energy, healthcare, metals, and electronics. Air Products generated $10.3 billion in revenue in fiscal 2021.
Read more on APD →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
